AAV-Mediated Inclusion Formation as a Novel Gene Therapy Strategy for ALS – Video




AAV-Mediated Inclusion Formation as a Novel Gene Therapy Strategy for ALS
Ole Isacson, Ph.D., McLean Hospital. Dr. Isacson is a CDMRP-funded investigator supported by the DoD Amyotrophic Lateral Sclerosis Research Program (ALSRP).

By: CDMRP

Follow this link:

AAV-Mediated Inclusion Formation as a Novel Gene Therapy Strategy for ALS - Video

Related Posts

Comments are closed.